We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Short CommunicationOpen Accesscc iconby icon

Differential gene expression profile of Shigella dysenteriae causing bacteremia in an immunocompromised individual

    Dhiviya Prabaa Muthuirulandi Sethuvel

    Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India

    ,
    Naveen Kumar Devanga Ragupathi

    Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India

    ,
    Marilyn M Ninan

    Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India

    ,
    Joy Sarojini Michael

    Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India

    ,
    Shalini Anandan

    Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India

    &
    Balaji Veeraraghavan

    *Author for correspondence: Tel.: +91 944 221 0555;

    E-mail Address: vbalaji@cmcvellore.ac.in

    Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India

    Published Online:https://doi.org/10.2144/fsoa-2019-0117

    Abstract

    Aim:Shigella species has varying levels of virulence gene expression with respect to different sites of infection. In this study, the differential gene expression of S. dysenteriae in response to its site of infection was analyzed by transcriptomics. Methods: This study includes four clinical Shigella isolates. Transcriptomics was done for the stool and blood samples of a single patient. Isolates were screened for the presence of antimicrobial resistance genes. Results: The majority of genes involved in invasion were highly expressed in the strain isolated from the primary site of infection. Additionally, antimicrobial resistance (dhfr1A, sulII, blaOXA. blaCTX-M-1 and qnrS) genes were identified. Conclusion: This study provides a concise view of the transcriptional expression of clinical strains and provides a basis for future functional studies on Shigella spp.

    Lay abstract

    Shigella infection is restricted to the gastrointestinal tract and rarely causes fatal extra-intestinal complications like bacteremia. There are limited studies available from India on molecular characterization of Shigella spp. In this study, we characterized four Shigella isolates obtained from bloodstream infections. Shigella spp. isolated from the stool and blood of one representative patient was further sequenced to study the differential gene expression profile. The differential protein expression by S. dysenteriae observed in this study demonstrates that it has a specific response to particular intracellular environments. Further, the in vivo mechanism of Shigellae invasion are difficult to fully study until the intracellular environment is mimicked in vitro. To the best of our knowledge, this is the first Indian study that compared the gene expression profile of clinical Shigella strains.

    Diarrheal disease is the second leading cause of mortality in children according to WHO [1]. Shigella spp. is one of the important causes of dysentery globally and causes severe and occasionally life-threatening diarrheal infection. In Asia, it is estimated that there are 125 million infections and 14,000 deaths due to shigellosis annually [2]. Clinically, the infection may lead to rare but potentially fatal extra-intestinal complications like bacteremia. Though, bacteremia due to Shigella spp. is rare, it is reported in 0.4–7% of the cases. Notably, young age, malnutrition and immunosuppression are known to be the risk factors for Shigella spp. bacteremia [3].

    Bacteria have developed various mechanisms to adhere to the organ surfaces. Some bacteria can adopt an intracellular lifestyle and get internalized inside various host cell types to replicate. Finally, pathogenic bacteria can get access to deeper tissues using various mechanisms to cross mucosal barriers and access the bloodstream, which is a gateway for all host organs [4].

    Pathogens showing a variable expression of virulence factors have been observed. In fact, the expression of virulence factors depends largely on the environmental conditions. This expression of virulence genes is induced under conditions similar to those found at the site of invasion. Studies have demonstrated that a temperature of 37°C is a favorable growth condition for bacteria in intestinal epithelial cells, but bacteria grown at 30°C can be phenotypically avirulent and noninvasive [5]. The bacterium can be found either in the intestinal lumen, inside epithelial cells, phagocytes or in the bloodstream. The expression level of virulence factors in these different locations varies accordingly in order to counteract different host defense mechanisms, as reported earlier by Ribet and Cossart [4].

    In this study, Shigella strains causing bacteremia were characterized using RNA-Sequencing to identify genes that are differentially expressed based on the site of infection. The genes responsible for invasion, virulence, stress, antimicrobial resistance (AMR) and other genes involved in cellular metabolism are also discussed.

    Materials & methods

    Strains

    This study reports four cases of Shigella bacteremia diagnosed between the years 2015 and 2018. The identified isolates include two isolates each of S. flexneri serotype 2 and S. dysenteriae serotype 9. The isolates were confirmed by standard biochemical tests [6]. The isolate was serotyped using commercial antisera as per the manufacturer’s instructions (Denka Seiken, Tokyo, Japan). For transcriptome analysis, stool (FC3355) and blood (BA42767) samples of the sole patient were studied further. Patient’s symptoms, clinical diagnosis and outcome were detailed in Table 1. The term invasive (sterile site) and noninvasive (nonsterile site) refer to the pathogen isolation site in this study.

    Table 1. Case details of Shigellemia reported in this study.
    IDYearSpeciesAge/sexUnitGI symptomsClinical diagnosisOutcome
    BA128272015S. flexneri 2 68/MMedicineNo symptomsDM uncontrolledExpired
    BA42767 FC3355 2015S. dysenteriae 9 54/MNephrologyFever, loose stool, vomitingRenal transplant on immunosuppressantsAlive
    BA218712016S. dysenteriae 9 65/MHematologyAcute gastroenteritisMultiple myloma, Shigella septicemiaAlive
    BA107462018S. flexneri 2 27/MMedicineNo symptomsPresented with cognitive behavior, decreased appetiteAlive

    †Isolate sequenced.

    BA: Blood; DM: Diabetes mellitus; FC: Feces; GI: Gastrointestinal.

    Antimicrobial susceptibility testing

    Antimicrobial susceptibility testing of isolates against ampicillin (10 μg), trimethoprim/sulphamethoxazole (1.25/23.75 μg), nalidixic acid (30 μg), ciprofloxacin (5 μg), norfloxacin (10 μg), ofloxacin (5 μg), cefpodoxime (10 μg), cefepime (30 μg), cefotaxime (30 μg), cefixime (5 μg), azithromycin (15 μg), imipenem (10 μg), meropenem (10 μg), amikacin (30 μg), gentamicin (10 μg), netilmicin (30 μg) and piperacillin/tazobactam (100/10 μg) was performed using Kirby–Bauer disc diffusion method. The results were interpreted using breakpoints recommended by the Clinical and Laboratory Standards Institute Guidelines 2018 [7]. Quality control strains used were Escherichia coli ATCC 35218, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 for the antibiotics tested.

    AMR genes PCR

    Genomic DNA was extracted using the QiaSymphony DNA extraction platform (Qiagen, Hilden, Germany). The isolates were screened for the presence of AMR (dhfr1A, sulII, blaOXA. blaCTX-M-1 and qnrS) genes by PCR as described earlier [8,9].

    RNA isolation

    Total RNA was extracted using RNeasy Mini kit (Cat#74106, Qiagen, GmBH, Germany) according to the manufacturer’s recommendations. The RNA was checked using the Qubit® 3.0 Fluorometric Quantitation kit (Invitrogen, Merelbeke, Belgium).

    RNA-sequencing & analysis

    The invasive traits of selected isolates were studied by comparing the differential gene expression profile of the strain isolated exclusively from stool and blood specimen concurrently by transcriptomics. RNA-sequencing procedure was performed according to the manufacturer’s instructions using Ion Torrent (PGM) sequencer with 400-bp read chemistry (Life Technologies, CA, USA) [10]. The quality and quantity of each library was determined at each step with a Qubit® 3.0 Fluorometer. De novo assembly using AssemblerSPAdes and annotation through RNA-Seq analysis was performed in PATRIC, the bacterial bioinformatics database and analysis resource.

    Statistical analysis

    In this study, greater than twofold changes in the gene expression level between two variables was considered significant. Results were analyzed for correlation and tested for significance by Student’s t-test (p < 0.05). SPSS 16.0 and Microsoft Excel 2007 (IL, USA) were used for the statistical evaluation.

    Results & discussion

    Shigella infection is in the majority confined to the GI tract which invades the colonic mucosa but rarely penetrates further into deeper tissues [11]. This study discusses four cases of Shigella bacteremia. The risk factors observed in these patients were diabetes, malignancy and immunosuppressant therapy. Previous literatures on mechanisms of pathogenesis have been described for S. flexneri. However, the present study has shown the invasion process of S. dysenteriae serotype 9.

    AMR gene PCR

    Among the four isolates studied, only two isolates harbored AMR genes that codes for β-lactams, trimethoprim/sulfamethoxazole, fluroquinolones and cephalosporins, whereas no AMR genes were identified in the other two isolates. The resistance genes obtained in this study were found to be a common profile seen in the genus. The results were given in Table 2. AMR was generally more common in Shigella than in other enteric bacteria [12].

    Table 2. Antimicrobial resistance profile of the study isolates.
    Sample IDSpeciesResistant profileAMR genes
    BA12827S. flexneri 2 R– CPD, CIP; MS - GEN, AK, P/TblaOXA. sulII, dhfr1a, qnrS, blaCTX-M-1
    BA42767 F3355S. dysenteriae 9 R – NAL, GEN, AK
    BA21871S. dysenteriae 9 R – SXT; MS - CIP, OFL, TAX, FEP, NALsulII, dhfr1a, qnrS
    BA10746S. flexneri 2 R – AMP

    AMP: Ampicillin; AK: Amikacin; BA: Blood; CIP: Ciprofloxacin; CPD: Cefpodoxime; FC: Feces; FEP: Cefepime; GEN: Gentamicin; MS: Moderate susceptible; NAL: Nalidixic acid; OFL: Ofloxacin; P/T: Piperacillin/tazobactam; R: Resistant; SXT: Trimethoprim/sulfamethoxazole; TAX: Cefotaxime.

    Differential gene expression analysis

    S. dysenteriae serotype 9 obtained from stool and blood specimen of the single patient was studied. In RNA-Seq analysis, significant fold change was observed between non-invasive Sd_FC3355 and invasive Sd_BA42767 strains for the genes involved in invasion, virulence, motility and other cellular processes. Totally 56 genes were differentially expressed between the strains. Of these, few genes were expressed only in invasive strain Sd_BA42767 like csp, dcm, hisE and enterotoxin genes with reduced expression, this showed the significance of these genes in the invasive phenotype of the strain. The majority of the genes (44/56 genes) were highly expressed in non-invasive isolate from the gut, which is the primary site of invasion for Shigella infection. Genes with no expression data were excluded from the analysis. The genes analysed were given as a supplementary material.

    Motility-associated genes

    Shigella pathogenesis involves bacterial invasion and spread through colonic mucosa [13]. Shigella spp. are able to move through the cytoplasm of host cells and into adjacent cells by polymerizing actin [14] which is mediated by IcsA (virG), encoded on the 220-kb virulence plasmid [15,16]. We observed that IcsA protein was expressed only in noninvasive Shigella isolate (Table 3). This correlates with the fact that IcsA is required for inter- and intracellular spreading of Shigella within the host intestinal epithelium. VirK gene, which is required for post-transcriptional regulation of icsA expression, has also been expressed.

    Table 3. Gene expression profile of the two selected isolates represented in fold change.
    GenesProductFold change
      Sd_FC3355Sd_BA42767
    SDY_0834/ipaH_1Invasion plasmid antigen/internalin, putative661
    SDY_1062/ipaH_3Invasion plasmid antigen/internalin, putative217
    SDY_2001/ipaH_4Invasion plasmid antigen/internalin, putative30
    SDY_2003/ipaH_5Invasion plasmid antigen/internalin, putative110
    SDY_2753/ipaH_6Invasion plasmid antigen/internalin, putative260
    SDY_P003/ospBHypothetical protein50
    SDY_P004/phoN2/apy Hypothetical protein180
    SDY_P010/ospD2Enterotoxin4045
    SDY_P023/ospD1OspD13610
    SDY_P025/ipgB2Putative chaperone (IpgB2)16720
    SDY_P037/ipaH4.5Invasion plasmid antigen/internalin, putative200
    SDY_P038/ipaH7.8Invasion plasmid antigen/internalin, putative230
    SDY_P045/ipaH1.4Invasion plasmid antigen/internalin, putative210
    SDY_P055/ospC1Hypothetical protein150
    SDY_P056/ospD3Enterotoxin1610
    SDY_P070/ospC2Hypothetical protein11110
    SDY_P099/ipaH9.8Invasion plasmid antigen/internalin, putative170
    SDY_P109/virKVirulence factor VirK365236
    SDY_P140/ipaHInvasion plasmid antigen/internalin, putative980
    SDY_P151/ospC3Hypothetical protein2240
    SDY_P160/ipaJUDP-sugar hydrolase (EC 3.6.1.45); 5′-nucleotidase (EC 3.1.3.5)11700
    SDY_P161/virBChromosome (plasmid) partitioning protein ParB760
    SDY_P163/ipaAHypothetical protein540
    SDY_P164/ipaDType III secretion host injection protein (YopB)1790
    SDY_P165/ipaCHypothetical protein12440
    SDY_P166/ipaBCell invasion protein SipB15820
    SDY_P167/ipgCType III secretion chaperone protein for YopD (SycD)9370
    SDY_P169/ipgAChaperone ipgA6130
    SDY_P170/icsBHypothetical protein4950
    SDY_P171/ipgDInositol phosphate phosphatase ipgD (EC 3.1.3)33990
    SDY_P173/ipgFInvasion protein IagB precursor32350
    SDY_P174/mxiGHypothetical protein16110
    SDY_P175/mxiHMxiH protein14500
    SDY_P177/mxiJType III secretion bridge between inner and outermembrane lipoprotein (YscJ, HrcJ, EscJ, PscJ)14570
    SDY_P179/mxiNMxiN14760
    SDY_P183/mxiDType III secretion outermembrane pore-forming protein (YscC, MxiD, HrcC, InvG)3340
    SDY_P184/mxiCType III secretion outermembrane contact-sensing protein (yopN, Yop4b, LcrE)3550
    SDY_P185/mxiAType III secretion inner membrane channel protein (LcrD, HrcV, EscV, SsaV)1600
    SDY_P186/spa15Spa151850
    SDY_P187/spa47Type III secretion cytoplasmic ATP synthase (EC 3.6.3.14, YscN, SpaL, MxiB, HrcN, EscN)4830
    SDY_P189/spa32Hypothetical protein3080
    SDY_P190/spa33Type III secretion innermembrane protein (YscQ, homologous to flagellar export components)2330
    SDY_P191/spaPType III secretion innermembrane protein (YscR, SpaR, HrcR, EscR, homologous to flagellar export components); surface presentation of antigens protein SpaP1160
    SDY_P191a/spa9Surface presentation of antigens protein SpaQ710
    SDY_P192/spa29Type III secretion innermembrane protein (YscT, HrcT, SpaR, EscT, EpaR1, homologous to flagellar export components)280
    SDY_P193/spa40Type III secretion innermembrane protein (YscU, SpaS, EscU, HrcU, SsaU, homologous to flagellar export components)330
    SDY_P211/virAHypothetical protein430
    SDY_P214/icsAHypothetical protein4690
    SDY_P224/icsPProtease VII (Omptin) precursor (EC 3.4.23.49)4610
    SD1617_4624/Virulence factor MviM095
    SD1617_3340/Enterotoxin03
    /Enterotoxin02
    SD1617_0737/ilvBAcetolactate synthase large subunit (EC 2.2.1.6)81476
    SD1617_0939/ilvDDihydroxy-acid dehydratase (EC 4.2.1.9)91405
    SD1617_0940/ilvAThreonine dehydratase biosynthetic (EC 4.3.1.19)59380
    SD1617_0942/ilvCKetol-acid reductoisomerase (EC 1.1.1.86)133268
    SD1617_0938/ilvEBranched-chain amino acid aminotransferase (EC 2.6.1.42)58225
    SD1617_3738/ilvNAcetolactate synthase small subunit (EC 2.2.1.6)417
    /IlvBN operon leader peptide0687
    SDY_2022/phoPTranscriptional regulatory protein PhoP222472
    SDY_2023/phoQSensor histidine kinase PhoQ (EC 2.7.13.3)136117
    SDY_3003/barASignal transduction histidine-protein kinase BarA (EC 2.7.13.3)2413
    SDY_1104/uvrYBarA-associated response regulator UvrY (= GacA = SirA)261314
    SDY_2892/csrACarbon storage regulator1021662
    SD1617_4387/hisFImidazole glycerol phosphate synthase cyclase subunit (EC 4.1.3)31189
    SD1617_4390/hisBHistidinol-phosphatase (EC 3.1.3.15)/imidazoleglycerol-phosphate dehydratase (EC 4.2.1.19)28186
    SD1617_4391/hisCHistidinol-phosphate aminotransferase (EC 2.6.1.9)13161
    SD1617_4388/hisAPhosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase (EC 5.3.1.16)28132
    SD1617_4392/hisDHistidinol dehydrogenase (EC 1.1.1.23)3132
    SD1617_4386/hisEPhosphoribosyl-AMP cyclohydrolase (EC 3.5.4.19)/phosphoribosyl-ATP pyrophosphatase (EC 3.6.1.31)096
    SD1617_4393/hisGATP phosphoribosyltransferase (EC 2.4.2.17) - HisGl5399
    SDY_2218/hisHImidazole glycerol phosphate synthase amidotransferase subunit (EC 2.4.2)22254
    SD1617_4262/Cold shock protein of CSP family - CspA (naming convention as in E. coli)39912120
    SDY_2381/cspDCold shock protein CspD229145
    SDY_0546/cspECold shock protein CspE1714222
    SD1617_4774/Cold shock protein of CSP family - CspC (naming convention as in E. coli)02569
    SDY_4448/groESHeat shock protein 60 family co-chaperone GroES35312405
    SDY_4449/groELHeat shock protein 60 family chaperone GroEL39943209
    SDY_4172/ibpB16 kDa heat shock protein B14691
    SDY_4173/ibpA16 kDa heat shock protein A190170
    SDY_2787/grpEHeat shock protein GrpE491409
     Heat shock protein C615
    SDY_3677/hslO33 kDa chaperonin (Heat shock protein 33) (HSP33)274133
    SD1617_5932/dcmDNA-cytosine methyltransferase (EC 2.1.1.37)0117
    SDY_4150/uhpATranscriptional regulatory protein UhpA1755
    SDY_4659/creBResponse regulator CreB of two-component signal transduction system CreBC4225
    SDY_4658/creAConserved uncharacterized protein CreA120122
    SDY_4477/evgAPositive transcription regulator EvgA17641
    SDY_4478/evgSHybrid sensory histidine kinase in two-component regulatory system with EvgA1212
    SDY_3723/hydHSensor protein of zinc sigma-54-dependent two-component system6854
    SDY_3722/hydGResponse regulator of zinc sigma-54-dependent two-component system7640
    SDY_1275/narLNitrate/nitrite response regulator protein NarL6619
    SDY_1276/narXNitrate/nitrite sensor protein NarX3134
    SDY_3874/glnLNitrogen regulation protein NtrB (EC 2.7.13.3)6967
    SDY_3875/glnGNitrogen regulation protein NtrC82106
    SDY_3214/ygiXTwo-component system response regulator QseB2533
    SDY_3213/qseCSensory histidine kinase QseC2124
    SDY_0856/rcsCSensor histidine kinase RcsC (EC 2.7.13.3)3232
    SDY_0857/rcsBDNA-binding capsular synthesis response regulator RcsB870899
    SDY_1824/rstATranscriptional regulatory protein RstA8654
    SDY_1825/rstBSensory histidine kinase in two-component regulatory system with RstA6056
    SDY_2744/yfhATranscriptional response regulatory protein GlrR4441
    SDY_2746/yfhKSensor histidine kinase GlrK6448
    SDY_4443/dcuAC4-dicarboxylate transporter DcuA225250
    SDY_2186/baeRResponse regulator BaeR5334
    SDY_2187/baeSSensory histidine kinase BaeS61
    SDY_1046/vsrVery-short-patch mismatch repair endonuclease (Guanine–Thymine [G–T] specific)028
    SDY_1047/yedAUncharacterized innermembrane transporter YedA00
    SDY_1048/yedIInnermembrane protein YedI00
    SDY_1970/Uncharacterized protein YobF302205

    0: Not expressed.

    Virulence/invasion associated genes

    Shigella virulence plasmid is an essential virulence determinant of the species and encodes the molecular machinery necessary for tissue invasion and intracellular survival. The virulence plasmid encodes the 30 kb Mxi-Spa type III secretion system (T3SS) and invasion plasmid antigens (Ipa proteins) required for invasion of the colonic and rectal epithelial cells and cell-to-cell spread of the bacteria, resulting in the symptoms of bacillary dysentery [17,18]. Shigella pathogenesis mainly relies on the Mxi-Spa T3SS and its effector proteins [19]. The invasion plasmid antigen (ipaH) gene, which was reported to be carried by all four Shigella species, was found to be highly expressed in invasive isolate in this study, whereas ipaD, a host injection protein was expressed only in noninvasive isolate. Further, ipgA, B, C, D, F known to facilitate local invasion in to epithelial cells, were also expressed only in noninvasive isolates (Table 3). Therefore, the virulence plasmid is the key molecular signature of Shigella spp. pathogenesis and is fundamental for initiating infection and manipulating the immune response of the host [18].

    PhoQ/PhoP is a two-component system that governs virulence and regulates several cellular activities in Shigella spp. [20]. In the present study, PhoP was highly expressed in invasive isolate, whereas PhoQ showed no significant difference in the expression level. In addition, BarA-UvrY two-component system was shown to have increased expression in invasive isolate. This system also controls the activity of CsrA (carbon storage regulator) protein which regulates carbon metabolism, flagellar biosynthesis and biofilm formation. This process has been previously reported in uropathogenic E. coli [21]. We observed that CsrA protein was upregulated in noninvasive isolate.

    Stress-associated genes

    Bacteria have developed a number of mechanisms to adapt the changing environmental conditions within the cells. One such mechanism is the production of small cold shock proteins (Csp) to counteract the sudden temperature downshift. Csps have been shown to contribute to osmotic, oxidative, starvation, pH and ethanol stress tolerance as well as to host cell invasion [22]. CspA is a major cold shock protein, first described in E. coli [22] was found to have significant differences in the expression level between the invasive and noninvasive isolate. Similarly, CspD and CspE proteins showed significant differences in their expressions, whereas CspC was highly and solely expressed in invasive isolate (Table 3). Another defense mechanism against various environmental stresses is the production of heat shock proteins. Heat shock proteins that are important for cell survival and are usually related to the virulence of the pathogens have been expressed in both the isolates [23].

    Genes involved in metabolism

    In this study, ilv proteins such as ilvA, B, C, D, E and N involved in amino acid biosynthesis showed significantly increased expression in invasive isolate. Histidine (his) proteins like hisA, B, C, D, E, F, G and H were found to have significant upregulation in invasive isolate. Further, member of the two-component regulatory system NtrB/NtrC and other regulator proteins like NarL and NarX involved in the regulation of nitrogen was expressed in both the isolates with no significant difference in the expression level. Similarly, several other genes such as (ygiX, qseC, rcsC, rcsB, rstA, rstB, yfhA, yfhK, dcuA, baeR, baeS, vsr) were present but showed no significant difference between the isolates.

    Cellular process & signaling

    During Shigella infection, certain effector proteins promote cell survival. IpgD which associated with increased intracellular bacterial replication [24] was highly and solely expressed in noninvasive isolate as expected. Further ospC and virA were also found to be expressed in noninvasive isolate [24]. DNA methylation is an important component in numerous cellular processes and plays an important role in regulating gene expression [25,26]. DNA cytosine methyltransferase protein was only slightly expressed in invasive isolate in this study.

    Uncharacterized genes

    Two genes encoding uncharacterized proteins were identified. Uncharacterized innermembrane transporter YedA gene was not expressed in the study isolates, which has been previously identified as hypothetical protein in S. dysenteriae strain Sd197. Another gene named YobF, which is a small protein with no known function showed significantly increased expression in invasive isolate. Yet the functions of these genes remain obscure.

    Conclusion & future perspective

    Shigella spp. is a highly contagious pathogen and humans are the only reservoir that spreads through fecal–oral contamination. The invasive ability of this pathogen is a key determinant in the establishment of the disease. The invasive phenotype of Shigella spp. is linked to the expression of various effector/regulatory genes. The differential protein expression by S. dysenteriae serotype 9 observed in this study suggests that it has a specific response to particular intracellular environment. Notably, many uncharacterized genes with unknown functions demonstrate the complexity of the regulatory network in S. dysenteriae. These genes needs to be further characterized to understand unidentified strategies for infection and successful survival of this pathogen. Further, the in vivo mechanism of S. dysenteriae invasion are difficult to fully study until the intracellular environment is mimicked in vitro. To the best of our knowledge, this is the first Indian study that compares the gene expression profile of clinical S. dysenteriae serotype 9 with respect to their invasion.

    Executive summary
    • Most of the earlier studies on mechanisms underlying pathogenesis was derived from Shigella flexneri. However, the present study shows the invasion process of Shigella dysenteriae serotype 9.

    • RNA sequencing was done to study the differential expression of genes involved in the invasion process of the pathogen with the respect to the infection site.

    • On virulence analysis, enterotoxin gene (set) and invasion associated genes such as ipaH and ial was identified in two, one and three isolates, respectively.

    • For antimicrobial resistance, only two isolates harbored genes that codes for β-lactams, trimethoprim/sulfamethoxazole, fluroquinolones and cephalosporins resistance.

    • RNA-Seq analysis showed significant fold change between noninvasive Sd_FC3355 and invasive Sd_BA42767 strains for the genes involved in invasion, virulence, motility and other cellular processes.

    • Majority of the genes (44/56 genes) were highly expressed in noninvasive isolate, which is the primary site of invasion for Shigella spp. Few genes were expressed only in invasive isolate Sd_BA42767, which shows the significance of these genes in the invasive phenotype of the strain.

    • This study explores that Shigella spp. has a specific response to particular intracellular environment.

    • The identification of genes with uncharacterized functions demonstrates the complexity of the regulatory network in S. dysenteriae.

    Author contributions

    B Veeraraghavan and S Anandan conceptualized the study. DP Muthuirulandi Sethuvel and NK Devanga Ragupathi analyzed, interpreted data and wrote the manuscript. DP Muthuirulandi Sethuvel carried out bench work and generated data. B Veeraraghavan, MM Ninan and JS Michael critically revised and approved the manuscript. All authors read and approved the manuscript.

    Acknowledgments

    The authors gratefully acknowledge the Institutional Review Board for approving the study and the department of Clinical Microbiology for providing lab space and facilities.

    Financial & competing interests disclosure

    The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

    No writing assistance was utilized in the production of this manuscript.

    Ethical conduct of research

    The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.

    Open access

    This work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

    Nucleotide sequence accession number

    The raw sequence data were submitted to the National Center for Biotechnology Information Sequence Read Archive under Accession No. SRR6031691 (BA42767) and SRR6031692 (FC3355).

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Sambe-Ba B , Espie E , Faye ME et al. Community-acquired diarrhea among children and adults in urban settings in Senegal: clinical, epidemiological and microbiological aspects. BMC Infect. Dis. 13, 580 (2013).
    • 2. Thompson CN , Duy PT , Baker S . The rising dominance of Shigella sonnei: an intercontinental shift in the etiology of bacillary dysentery. PLoS Negl. Trop. Dis. 9, e0003708 (2015).
    • 3. Jain S , Sharma M , Gupta R , Shree N , Kumar M . Multidrug resistant Shigella flexneri: a rare case of septicemia in an infant. J. Clin. Diagn. Res. 8, DD03 (2014).
    • 4. Ribet D , Cossart P . How bacterial pathogens colonize their hosts and invade deeper tissues. Microb. Infect. 17, 173–183 (2015). •• Provides the detailed description of pathogenesis of Shigella in humans.
    • 5. Zhao G , Zhu L , Feng E et al. A novel anti-virulence gene revealed by proteomic analysis in Shigella flexneri 2a. Proteome Sci. 8, 30 (2010).
    • 6. Bopp CA , Brenner FW , Fields PL et al. Escherichia, Shigella, and Salmonella. In: Manual of Clinical Microbiology (8th Edition). Murray PR Baron EJ Jorgensen J Pfaller MA Yolken RH (Eds). American Society for Microbiology, DC, USA, 654–671 (2003).
    • 7. CLSI, Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement M100-S28. Clinical and Laboratory Standards Institute, MI, USA (2018).
    • 8. Thong KL , Hoe SLL , Puthucheary SD , Yasin RM . Detection of virulence genes in Malaysian Shigella species by multiplex PCR assay. BMC Infect. Dis. 5, 8 (2005). • Describes the application of multiplex PCR for the detection of important Shigella virulence genes.
    • 9. Anandan S , Sethuvel DPM , Gajendiren R , Verghese VP , Walia K , Veeraraghavan B . Molecular characterization of antimicrobial resistance in clinical Shigella isolates during 2014 and 2015: trends in South India. Germs 7, 115 (2017). • Reports the prevalence of various antimicrobial resistance genes among Shigella spp. in India.
    • 10. Castro TL , Seyffert N , Ramos RT et al. Ion Torrent-based transcriptional assessment of a Corynebacterium pseudotuberculosis equi strain reveals denaturing high-performance liquid chromatography a promising rRNA depletion method. Microb. Biotechnol. 6, 168–177 (2013).
    • 11. Carayol N , Van Nhieu GT . The inside story of Shigella invasion of intestinal epithelial cells. Cold Spring Harb. Perspect. Med. 3, a016717 (2013).
    • 12. Mamatha B , Rituparna C . Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India – a 5 year hospital based study. Southeast Asian J. Trop. Med. Public Health 43, 1447 (2012).
    • 13. Goldberg MB , Theriot JA . Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility. Proc. Natl Acad. Sci. USA 92, 6572–6576 (1995).
    • 14. Magdalena J , Goldberg MB . Quantification of Shigella IcsA required for bacterial actin polymerization. Cell Motil. Cytoskeleton 51, 187–196 (2002).
    • 15. Purdy GE , Fisher CR , Payne SM . IcsA surface presentation in Shigella flexneri requires the periplasmic chaperones DegP, Skp, and SurA. J. Bacteriol. 189, 5566–5573 (2007).
    • 16. Teh MY , Morona R . Identification of Shigella flexneri IcsA residues affecting interaction with N-WASP, and evidence for IcsA–IcsA co-operative interaction. PLoS ONE 8, e55152 (2013).
    • 17. Yang F , Yang J , Zhang X et al. Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res. 33, 6445–6458 (2005).
    • 18. The HC , Thanh DP , Holt KE , Thomson NR , Baker S . The genomic signatures of Shigella evolution, adaptation and geographical spread. Nat. Rev. Microbiol. 14, 235 (2016).
    • 19. Yang SC , Hung CF , Aljuffali IA , Fang JY . The roles of the virulence factor IpaB in Shigella spp. in the escape from immune cells and invasion of epithelial cells. Microbiol. Res. 181, 43–51 (2015).
    • 20. Cai X , Zhang J , Chen M et al. The effect of the potential PhoQ histidine kinase inhibitors on Shigella flexneri virulence. PLoS ONE 6, e23100 (2011).
    • 21. Palaniyandi S , Mitra A , Herren CD et al. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073. PLoS ONE 7, e31348 (2012).
    • 22. Keto-Timonen R , Hietala N , Palonen E , Hakakorpi A , Lindstrom M , Korkeala H . Cold shock proteins: a minireview with special emphasis on Csp-family of enteropathogenic Yersinia. Front. Microbiol. 7, 1151 (2016).
    • 23. Harikrishnan H , Ismail A , Singh KKB . Temperature-regulated expression of outer membrane proteins in Shigella flexneri . Gut Pathog. 5, 38 (2013).
    • 24. Lu R , Herrera BB , Eshleman HD et al. Shigella effector OspB activates mTORC1 in a manner that depends on IQGAP1 and promotes cell proliferation. PLoS Pathog. 11, e1005200 (2015).
    • 25. Lim DH , Maher ER . DNA methylation: a form of epigenetic control of gene expression. Obstet. Gynecol. 12, 37–42 (2010).
    • 26. Gomez-Eichelmann MC , Levy-Mustri A , Ramirez-Santos J . Presence of 5-methylcytosine in CC (A/T) GG sequences (Dcm methylation) in DNAs from different bacteria. J. Bacteriol. 173, 7692–7694 (1991).